Iron casein succinylate-chitosan coacervate for the liquid oral delivery of iron with bioavailability and stability enhancement

被引:14
作者
Min, Kyoung Ah [1 ,2 ]
Cho, Jung-Hye [3 ]
Song, Yun-Kyoung [3 ]
Kim, Chong-Kook [3 ]
机构
[1] Gyeongsang Natl Univ, Coll Pharm, Jinju 52828, Gyeongnam, South Korea
[2] Gyeongsang Natl Univ, Pharmaceut Sci Res Inst, Jinju 52828, Gyeongnam, South Korea
[3] Seoul Natl Univ, Coll Pharm, Seoul 08826, South Korea
基金
新加坡国家研究基金会;
关键词
Iron casein succinylate; Chitosan; Nanoparticle; Coacervation; Bioavailability; DRUG-DELIVERY; PROTEIN SUCCINYLATE; IN-VIVO; ABSORPTION; DERIVATIVES; DEFICIENCY; NANOPARTICLES; INVOLVEMENT; TRANSPORT; ACID;
D O I
10.1007/s12272-015-0684-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Iron casein succinylate (ICS) liquid oral preparation as iron supplement has uncomfortable taste after a long period of storage because of its stability, and poor bioavailability of iron compared to any other iron preparations. To improve the chemical stability of ICS and enhance the bioavailability of iron, chitosan-ICS nanoparticles (NPs) were prepared by complex coacervation method and stabilized with polyethylene glycol (PEG) 400. NPs were spherical (mean diameter of 830-1070 nm) with positive charge (+30-60 mV) depending on the composition of NPs. Addition of PEG400 (2 w/v %) increased the zeta potential (26-50 %) and physical stability of chitosan-ICS NPs suspension. Also, NPs decreased iron release compared to ICS after 7-weeks of storage at 4 A degrees C. NPs markedly increased the permeability of iron in Caco-2 cell up to 32-38-fold compared to ICS, while physical mixture of chitosan and ICS increased the iron permeability only 2.5-fold. In summary, NPs improved the physicochemical stability and enhanced the transport of iron compared to other iron preparations in Caco-2 cell model. Thus, chitosan-ICS coacervate might be a promising candidate as a liquid oral iron delivery system for iron deficiency patients with stability and bioavailability enhancement.
引用
收藏
页码:94 / 102
页数:9
相关论文
共 33 条
[1]  
Abbaspour N, 2014, J RES MED SCI, V19, P164
[2]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[3]   Chitosan-based hydrogels for controlled, localized drug delivery [J].
Bhattarai, Narayan ;
Gunn, Jonathan ;
Zhang, Miqin .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :83-99
[4]   Iron derivatives from casein hydrolysates as a potential source in the treatment of iron deficiency [J].
Chaud, MV ;
Izumi, C ;
Nahaal, Z ;
Shuhama, T ;
Bianchi, MDP ;
de Freitas, O .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2002, 50 (04) :871-877
[5]   In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery [J].
Chen, Fu ;
Zhang, Zhi-Rong ;
Yuan, Fang ;
Qin, Xuan ;
Wang, Minting ;
Huang, Yuan .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 349 (1-2) :226-233
[7]   Iron absorption: Biochemical and molecular insights into the importance of iron species for intestinal uptake [J].
Cremonesi, P ;
Acebron, A ;
Raja, KB ;
Simpson, RJ .
PHARMACOLOGY & TOXICOLOGY, 2002, 91 (03) :97-102
[8]  
CREMONESI P, 1993, INT J CLIN PHARM TH, V31, P40
[9]   Gum Arabic-chitosan complex coacervation [J].
Espinosa-Andrews, Hugo ;
Baez-Gonzalez, Juan G. ;
Cruz-Sosa, Francisco ;
Vernon-Carter, E. Jaime .
BIOMACROMOLECULES, 2007, 8 (04) :1313-1318
[10]   A comparative study on the gastroduodenal tolerance of different antianaemic preparations [J].
Gastearena, MAI ;
Gil, AG ;
Azqueta, A ;
Coronel, MP ;
Gimeno, M .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2003, 22 (03) :137-141